Review Article

Association of Interleukin 10 (IL-10) Gene Polymorphism (819T > C) with Susceptibility to Acute Myeloid Leukemia: A Meta-Analysis

Abstract

Background: Studies reported an association between interleukin (IL)-10 -819T>C polymorphism and the risk of developing Acute myeloid leukemia (AML), however due to inconsistency among these results, relationship between IL-10 -819T>C polymorphism and AML remained unclear. We herein performed this meta-analysis to investigate the association of IL-10 -819T >C polymorphism with the risk of AML.

Methods: A systematic search through PubMed, Embase, Scopus, Cochrane Library and OpenGrey was performed from inception to Jan 2021. Odds ratios (OR) with their corresponding 95% confidence intervals (CI) for five possible genetic models were calculated. Heterogeneity was assessed using the Cochran Q test and the I2 statistic. A total of 404 AML cases and 635 healthy controls were included in our meta-analysis.

Results: Our results indicated no statically significant association between IL-10 -819T>C polymorphism and the risk of developing AML; dominant model (OR=0.87, 95% CI=0.42–1.81); recessive model (OR=1.17, 95% CI = 0.43–3.16); allelic model (OR=1.00, 95% CI=0.54–1.88); CC vs. TT (OR=1.00,95% CI=0.30–3.36); and TC vs. TT (OR=0.80, 95%CI =0.46–1.37).

Conclusion: IL-10 -819T > C polymorphism is not associated with the risk of AML. However further studies focusing on other parameters such as sex, gene-gene interactions and environmental factors are required to reveal the true association of IL-10 -819T > C polymorphism with AML.

1. Coombs CC, Tallman MS, Levine RL (2016). Molecular therapy for acute myeloid leukaemia. Nat Rev Clin Oncol, 13:305-18
2. De Kouchkovsky I, Abdul-Hay M (2016). Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J, 6:e441.
3. Ilhan G, Karakus S, Andic N (2006). Risk factors and primary prevention of acute leukemia. Asian Pac J Cancer Prev, 7:515-7
4. Zhuo W, Zhang L, Wang Y, et al (2012). CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects. J Exp Clin Cancer Res, 31:62.
5. Qin Y-T, Zhang Y, Wu F, et al (2014). Association between MTHFR polymorphisms and acute myeloid leukemia risk: a meta-analysis. PLoS One, 9:e88823.
6. Guo C, Wen L, Song J-K, et al (2018). Significant association between interleukin-10 gene polymorphisms and cervical cancer risk: a meta-analysis. Oncotarget, 9:12365-75.
7. Rashed R, Shafik RE, Shafik NF, Shafik HE (2018). Associations of interleukin-10 gene polymorphisms with acute myeloid leukemia in human (Egypt). J CancerRes Ther, 14:1083-86.
8. Liu P, Song J, Su H, et al (2013). IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. PLoS One, 8:e69547.
9. Howell WM, Rose-Zerilli MJ (2007). Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr, 137(1 Suppl):194S-199S.
10. Fei C, Yao X, Sun Y, et al (2015). Interleukin-10 polymorphisms associated with susceptibility to acute myeloid leukemia. Genet Mol Res, 14:925-30.
11. Chenjiao Y, Zili F, Haibin C, et al (2013). IL-10 promoter polymorphisms affect IL-10 production and associate with susceptibility to acute myeloid leukemia. Pharmazie, 68:201-206.
12. Nursal AF, Pehlivan M, Sahin HH, Pehlivan S (2016). The Associations of IL-6, IFN-c, TNF-a, IL-10, and TGF-b1 Functional Variants with Acute Myeloid Leukemia in Turkish Patients. Genet Test Mol Biomarkers, 20(9):544-51.
13. Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA, 283:2008-2012.
14. Abyadeh M, Heydarinejad F, Khakpash M, et al (2020). Association of Apolipoprotein E gene polymorphism with Preeclampsia: a meta-analysis. Hypertens Pregnancy, 39(2):196-202
15. Peterson J, Welch V, Losos M, Tugwell P (2011). The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute.1-2.
16. Wigginton JE, Cutler DJ, Abecasis GR (2005). A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet, 76:887-893.
17. Raoufi A, Kelarijani Br, Ahadi Hr, et al (2021). Association of MTHFR C677T and A1298C Polymorphisms with Susceptibility to Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis. Iran J Public Health, 50:83-92.
18. Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J (2006). Assessing heterogeneity in meta-analysis: Q statistic or I² index? Psychol Methods, 11:193-206.
19. Asefi Y, Gohari Mahmoudabad A, Habibian Sezavar A, Mirshahvaladi S, Abyadeh M, Abyareh M (2020). Association between maternal cadmium exposure and preterm birth: a meta-analysis. Int J Environ Health Res, 1-10.
20. Egger M, Smith GD, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315:629-634.
21. Collins FS, Brooks LD, Chakravarti A (1998). A DNA polymorphism discovery resource for research on human genetic variation. Genome Res, 8:1229-1231.
22. Schwender H, Ruczinski I, Ickstadt K (2011). Testing SNPs and sets of SNPs for importance in association studies. Biostatistics, 12:18-32.
23. Razi B, Anani Sarab G, Omidkhoda A, Alizadeh S (2018). Multidrug resistance 1 (MDR1/ABCB1) gene polymorphism (rs1045642 C> T) and susceptibility to multiple myeloma: a systematic review and meta-analysis. Hematology, 23:456-462.
24. Abyadeh M, Djafarian K, Heydarinejad F, Alizadeh S, Shab-Bidar S (2019). Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis. J Mol Neurosci, 69(4):557-562.
25. Binder S, Luciano M, Horejs-Hoeck J (2018). The cytokine network in acute myeloid leukemia (AML): A focus on pro-and anti-inflammatory mediators. Cytokine Growth Factor Rev, 43:8-15.
26. Ouma C, Davenport GC, Were T, et al (2008). Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production. Hum Genet, 124:515-524.
Files
IssueVol 51 No 1 (2022) QRcode
SectionReview Article(s)
DOI https://doi.org/10.18502/ijph.v51i1.8288
Keywords
Interleukin 10 Acute myeloid leukemia Polymorphism Meta-analysis
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Ahadi HR, Ebrahimi Sadrabadi A, Jalili A, Hajifathali A. Association of Interleukin 10 (IL-10) Gene Polymorphism (819T > C) with Susceptibility to Acute Myeloid Leukemia: A Meta-Analysis. Iran J Public Health. 2022;51(1):19-26.